Pfizer has completed 37 acquisitions in the past five years, with an average deal size of $2.9 billion and an average premium of 103 percent, according to data compiled by Bloomberg.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”